Kiniksa Pharmaceuticals International, plc — Investor Relations & Filings
Filings indexed
694
across all filing types
Latest filing
2026-05-26
Regulatory Filings
Country
US
United States of America
Listing
US
KNSA
Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutic medicines for patients with debilitating diseases and significant unmet medical needs. The company's portfolio is centered on immune-modulating assets. Its commercial product, ARCALYST® (rilonacept), is an interleukin-1α and interleukin-1β cytokine trap for the treatment of recurrent pericarditis and other autoinflammatory diseases. Kiniksa's clinical development pipeline includes investigational therapies such as KPL-387, a monoclonal antibody IL-1 receptor antagonist also being evaluated for recurrent pericarditis. The company concentrates its efforts in therapeutic areas including cardiovascular and autoimmune diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-26 | English | |
| 8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer) | 2026-04-28 | English | |
| DEF 14A - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G/A - Kiniksa Pharmaceuticals International, plc (0001730430) (Subject) | 2026-03-27 | English | |
| 4 - KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (0001730430) (Filer) | 2026-03-04 | English | |
| 10-K - KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (0001730430) (Filer) | 2026-02-24 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47073858 | 8-K | 2026-05-26 | English | ||
| 37972229 | 8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer) | 2026-04-28 | English | ||
| 34650077 | DEF 14A - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer) | 2026-04-16 | English | ||
| 33061107 | SCHEDULE 13G/A - Kiniksa Pharmaceuticals International, plc (0001730430) (Subject) | 2026-03-27 | English | ||
| 32897398 | 4 - KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (0001730430) (Filer) | 2026-03-04 | English | ||
| 32897402 | 10-K - KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (0001730430) (Filer) | 2026-02-24 | English | ||
| 32897400 | 8-K - KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (0001730430) (Filer) | 2026-02-24 | English | ||
| 31511698 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31511487 | 4 Filing | 2026-02-12 | English | ||
| 31511466 | 4 Filing | 2026-02-11 | English | ||
| 31511643 | 4 Filing | 2026-02-04 | English | ||
| 31511427 | 4 Filing | 2026-02-04 | English | ||
| 13092339 | 8-K | 2026-01-14 | English | ||
| 13092343 | 8-K | 2026-01-12 | English | ||
| 13092340 | Director's Dealing 2026 | 2026-01-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Kiniksa Pharmaceuticals International, plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31411/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31411 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31411 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31411 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31411}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kiniksa Pharmaceuticals International, plc (id: 31411)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.